Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
Clinical trial NCT00691210 · COMPLETED
Trial details
- NCT number
- NCT00691210
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.